Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharm-country crawled date : 2022 - 12 - 12 save search
Tonix Pharmaceuticals Announces Exclusive License of Potential Therapeutic or Preventative Humanized anti-SARS-CoV-2 Monoclonal Antibodies from Curia Global, Inc.
Published: 2022-12-12 (Crawled : 20:00) - biospace.com/
TNXP | $0.1587 1.21% 1.2% 950K
|
Health Technology
|
| O: 53.52%
H: 32.2%
C: -29.96%
pharmaceuticals license potential
Rocket Pharmaceuticals Presents Positive Clinical Data from Fanconi Anemia, Pyruvate Kinase Deficiency and Severe Leukocyte Adhesion Deficiency-I Programs at the 64th American Society of Hematology (ASH) Annual Meeting
Published: 2022-12-12 (Crawled : 18:00) - biospace.com/
RCKT 4 | $23.64 -0.13% -0.13% 920K
|
Health Technology
|
| O: 0.84%
H: 7.72%
C: 5.69%
pharmaceuticals meeting positive
Applied DNA to Report Fiscal 2022 Fourth Quarter and Year End Financial Results on December 14, 2022
Published: 2022-12-12 (Crawled : 17:00) - biospace.com/
APDN | $0.2418 -16.62% -19.93% 1.2M
|
Commercial Services
|
| O: 2.88%
H: 9.45%
C: 3.5%
report dna year financial results
Actinium Highlights Survival Data in Relapsed/Refractory AML Patients with Prior Venetoclax Treatment and/or with a TP53 Mutation from the Actimab-A CLAG-M Combination Trial Oral Presentation at ASH
Published: 2022-12-12 (Crawled : 14:00) - biospace.com/
ATNM | $7.06 1.44% 0.0% 150K
|
Health Technology
|
| O: -1.67%
H: 1.7%
C: 0.0%
tp53 treatment aml trial presentation
CSL Announces Closing of Global Collaboration and Licensing Agreement with Arcturus Therapeutics
Published: 2022-12-12 (Crawled : 14:00) - biospace.com/
ARCT 4 | $27.0 -3.33% -3.44% 270K
|
Health Technology
|
| O: 0.0%
H: 5.2%
C: 4.55%
global collaboration therapeutics agreement
Bristol Myers Squibb Announces First Disclosures and New Data at ASH 2022, Demonstrating Commitment to Raising Standards in Treatment Through Broad Multiple Myeloma Portfolio
Published: 2022-12-12 (Crawled : 13:00) - biospace.com/
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.14%
H: 0.25%
C: -0.06%
treatment
BrainStorm Cell Therapeutics Submits Type A Meeting Request to U.S. Food and Drug Administration
Published: 2022-12-12 (Crawled : 13:00) - biospace.com/
BCLI A | $0.5339 1.7% 1.67% 190K
|
Health Technology
|
| O: 2.19%
H: 34.28%
C: 32.86%
drug meeting therapeutics food
Merck Begins Tender Offer to Acquire Imago BioSciences, Inc.
Published: 2022-12-12 (Crawled : 12:00) - biospace.com/
IMGO | $36.01 0.03% 0.0% 0
|
Health Technology
|
| O: 0.01%
H: 0.15%
C: -0.11%
MRK | $127.0 0.1% -1.21% 7.1M
|
Health Technology
|
| O: -0.78%
H: 1.08%
C: 0.96%
acquire
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.